> In a new survey, an overwhelming majority of doctors say that Tysabri could be an effective therapy, but only 59 percent say it should be returned to the market. Article
> Weeks after H5N1 was confirmed in Nigeria, efforts to contain the disease are sporadic and many people are deeply distrustful of a government they view as dangerous and corrupt. In some cases, people are fleeing rather than submit to tests. Report
> British scientists have launched a new study of H5N1 in an attempt to help head off a potential pandemic. Article
> The FDA has accepted Genta's application for Genasense, an oncology candidate. Report
> Sanofi-Aventis has launched Apidra, a fast-acting insulin analog, in the U.S. Release
> Enzo has received approval to launch an HIV clinical trial. Release
And Finally… Susan Wood, who resigned from the FDA several months ago, said it's clear that acting agency chief Andrew von Eschenbach will continue to allow political concerns to trump the science that demands approval of Plan B. Editorial